WearLinq, a health tech firm, has unveiled eWave. It’s the world’s smallest, lightest, and first 24/7 ECG wearable with flexible sensors.
The eWave is a medical-grade monitor that records a 6-lead ECG and sends it to your phone in real time to detect irregular cardiac beats. It was created at Stanford University’s world-renowned stretchable electronics lab.
ECG sensors in smartwatches have already been shown. The first thing that comes to mind is the Apple Watch, but there are others. One feature that distinguishes eWave is its ability to provide continuous ECG monitoring. Others often provide 30 second on-demand clips, which, while valuable, may miss arrhythmia episodes.
The battery life is around three days on a single charge, which implies that you can have that many days of continuous readings. There is also a charging case that can give 12 days of monitoring while on the go.
According to the manufacturer, the device can detect atrial fibrillation, bradycardia, tachycardia, and normal heart rhythm. If something is wrong, there is an accompanying smartphone app that allows consumers to communicate directly with physicians and schedule same-week cardiologist e-visits. This shortens the customary four-month period between the development of symptoms and diagnosis to just two weeks.
Another advantage of utilising eWave is that it contains 6-leads, which provides greater accuracy than the ECG sensors available in smartwatches. Furthermore, the device is relatively light (5.4 grammes) and compact (3.3 cm x 2.4 cm x 0.8 cm).
To use it, simply place the eWave on your chest like a bandage. It includes splash-proof stretchy electronics. This implies you can shower with it on but not bathe with it. Each patch lasts roughly a week, and each package contains 25 patches. After the launch, you’ll be able to order additional ones for $2 each.
eWave has just debuted on Indiegogo and is nearly halfway to its funding target with 30 days left. It will cost you $179 to get in. The wearable is anticipated to ship in May 2021, so the wait will be pretty long. One reason for the delay could be that the company will need FDA approval before selling the device.